E.GalluccioM.KandasamyR
And even though BPC-157 is gaining more and more attention from doctors, it is still not authorized by the FDA, and numerous unanswered issues about its long-term effects demand further investigation
Por otro lado, los estudios comparativos, como el de CagriSema frente a tirzepatida, ayudarn a definir cul tratamiento es el ms efectivo y seguro para cada caso
Beyond glycemia, GLP-1RAs also have beneficial effects on CV outcomes, and produce weight loss in a safe manner
J Neurochem 105:16561667 Basak I, Patil KS, Alves G, Larsen JP, Mller SG (2016) microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases
4-7 More than two-thirds of patients gain weight following breast cancer diagnosis, which is associated with worse all-cause mortality